Psychiatric Medication Management During Litigation

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 9 min read

Managing psychiatric medications during the litigation period presents unique challenges: treatment decisions must balance clinical need against documentation implications, medication changes coinciding with legal milestones may be scrutinized, and the stress of litigation itself can worsen psychiatric symptoms requiring treatment adjustment. Effective medication management during this period requires coordination between the pharmacist, prescriber, and attorney.

Managing psychiatric medications during the litigation period presents challenges that do not exist in standard clinical practice. Treatment decisions must balance clinical need against documentation implications. Medication changes that coincide with legal milestones may be scrutinized by opposing counsel. The stress of litigation itself -- depositions, independent medical examinations, uncertainty about case outcome -- can worsen psychiatric symptoms and necessitate treatment adjustments that must be clinically documented rather than appearing reactive to legal events.

• Litigation stress frequently worsens PTSD, anxiety, and insomnia, requiring medication adjustments during the case
• Medication changes should be clinically documented by the prescriber to prevent mischaracterization by defense
• Depositions and IMEs create specific pharmacological considerations (medication effects on testimony, pre-deposition anxiety management)
• LienScripts maintains continuous pharmacy lien coverage throughout the entire litigation period at zero upfront cost
• The medication timeline through litigation documents the ongoing impact of the injury on the patient's daily life

How Litigation Affects Psychiatric Symptoms

Deposition and IME Stress

Depositions require the patient to recount the accident in detail, reactivating traumatic memories and potentially triggering PTSD flashback, panic attacks, or acute anxiety episodes. Independent medical examinations (IMEs) by defense-hired physicians create adversarial interactions that elevate stress. Both events commonly trigger temporary psychiatric symptom worsening that may require medication adjustment.

Uncertainty and Prolonged Stress

Litigation can extend 12-36 months. The prolonged uncertainty about case outcome, combined with ongoing financial stress from the injury, creates a chronic stress state that maintains or worsens psychiatric symptoms. This is not malingering -- it is a well-documented phenomenon where external stressors maintain the neurobiological changes caused by the original trauma.

Re-Traumatization

Reviewing accident photos, reading medical records, and discussing the accident repeatedly with attorneys and medical providers constitutes re-exposure to the traumatic event. For patients with PTSD, this re-exposure can trigger symptom exacerbation that requires treatment intensification.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist with clinical experience in psychiatric pharmacy, explains: "Psychiatric medication management during litigation is a balancing act. The prescribing physician must treat the patient's evolving symptoms while maintaining clear clinical documentation that medication changes are driven by clinical need, not legal strategy. When an SSRI dose increase coincides with an upcoming deposition, the prescriber's note must document the symptom worsening that prompted the change."

Medication Considerations at Key Litigation Milestones

Pre-Deposition

Patients may experience acute anxiety before depositions. Short-term anxiolytic use (hydroxyzine 25-50 mg, propranolol 10-20 mg) can help the patient function during the deposition without impairing cognitive performance. Benzodiazepines before depositions are generally avoided because they can impair memory recall and potentially compromise testimony quality.

During IME

Patients should take their medications as prescribed on the day of an IME. The defense physician needs to evaluate the patient on their current medication regimen. Skipping medications to "appear worse" is inadvisable and may be discovered through pharmacy records.

Post-Settlement Transition

When the case settles, the pharmacy lien is resolved and the patient transitions to insurance-based or cash-pay medication coverage. This transition must be planned in advance to prevent treatment interruptions. Medication simplification or tapering may be appropriate if the patient's psychiatric condition has stabilized.

Documentation Principles During Litigation

Clinical Justification for Every Change

Every medication change during litigation should have a documented clinical rationale in the prescriber's notes. This protects against defense claims that medication changes were strategically timed to inflate damages.

Consistent Refill Patterns

Regular, consistent medication refills demonstrate treatment adherence and ongoing clinical need. Gaps in refills can be characterized as evidence that the medication was not needed. LienScripts monitors refill patterns and helps ensure continuous dispensing.

Avoiding Problematic Patterns

Sudden medication additions immediately before medical evaluations, dose increases timed to depositions without supporting clinical notes, or medication discontinuation shortly after settlement -- all of these patterns can be exploited by defense. Clinical documentation prevents mischaracterization.

The Pharmacy Lien Advantage During Litigation

The LienScripts pharmacy lien provides continuous medication coverage throughout the entire litigation period -- no matter how long the case takes. Patients never face insurance disruptions, prior authorization delays, or out-of-pocket costs that could create treatment gaps. This continuous coverage produces the strongest possible medication timeline for the demand package.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. The MERIT report captures the complete litigation-period medication timeline, including any adjustments prompted by litigation-related stress, with the clinical context necessary to support each medication decision.

Coordinating Care

Effective psychiatric medication management during litigation requires coordination among three parties:

1. Prescribing physician: Makes treatment decisions based on clinical need, documents rationale
2. Pharmacist (LienScripts): Monitors adherence, screens interactions, provides MERIT documentation
3. Attorney: Understands how medication records will be used in the case, communicates upcoming milestones that may trigger symptom worsening

This coordination ensures the patient receives optimal care while the medication record serves its dual clinical and evidentiary purposes.

Related Resources

• Polypharmacy in Psychiatric Medications After an Accident
• Psychiatric Medication Impact on Case Value: Attorneys
• How to Read a MERIT Report: Attorneys